S&P 500   3,135.96 (-0.32%)
DOW   27,909.60 (-0.38%)
QQQ   204.07 (-0.45%)
AAPL   266.92 (-1.40%)
FB   201.34 (+0.14%)
MSFT   151.36 (-0.26%)
GOOGL   1,342.99 (+0.27%)
AMZN   1,749.51 (-0.12%)
CGC   21.29 (+14.16%)
NVDA   212.17 (+0.00%)
MU   46.45 (-3.09%)
BABA   198.74 (-1.56%)
TSLA   339.53 (+1.08%)
T   38.04 (-0.42%)
AMD   38.93 (-1.77%)
F   9.01 (-0.11%)
NFLX   302.50 (-1.58%)
GILD   66.93 (-0.22%)
DIS   146.21 (-0.98%)
S&P 500   3,135.96 (-0.32%)
DOW   27,909.60 (-0.38%)
QQQ   204.07 (-0.45%)
AAPL   266.92 (-1.40%)
FB   201.34 (+0.14%)
MSFT   151.36 (-0.26%)
GOOGL   1,342.99 (+0.27%)
AMZN   1,749.51 (-0.12%)
CGC   21.29 (+14.16%)
NVDA   212.17 (+0.00%)
MU   46.45 (-3.09%)
BABA   198.74 (-1.56%)
TSLA   339.53 (+1.08%)
T   38.04 (-0.42%)
AMD   38.93 (-1.77%)
F   9.01 (-0.11%)
NFLX   302.50 (-1.58%)
GILD   66.93 (-0.22%)
DIS   146.21 (-0.98%)
S&P 500   3,135.96 (-0.32%)
DOW   27,909.60 (-0.38%)
QQQ   204.07 (-0.45%)
AAPL   266.92 (-1.40%)
FB   201.34 (+0.14%)
MSFT   151.36 (-0.26%)
GOOGL   1,342.99 (+0.27%)
AMZN   1,749.51 (-0.12%)
CGC   21.29 (+14.16%)
NVDA   212.17 (+0.00%)
MU   46.45 (-3.09%)
BABA   198.74 (-1.56%)
TSLA   339.53 (+1.08%)
T   38.04 (-0.42%)
AMD   38.93 (-1.77%)
F   9.01 (-0.11%)
NFLX   302.50 (-1.58%)
GILD   66.93 (-0.22%)
DIS   146.21 (-0.98%)
S&P 500   3,135.96 (-0.32%)
DOW   27,909.60 (-0.38%)
QQQ   204.07 (-0.45%)
AAPL   266.92 (-1.40%)
FB   201.34 (+0.14%)
MSFT   151.36 (-0.26%)
GOOGL   1,342.99 (+0.27%)
AMZN   1,749.51 (-0.12%)
CGC   21.29 (+14.16%)
NVDA   212.17 (+0.00%)
MU   46.45 (-3.09%)
BABA   198.74 (-1.56%)
TSLA   339.53 (+1.08%)
T   38.04 (-0.42%)
AMD   38.93 (-1.77%)
F   9.01 (-0.11%)
NFLX   302.50 (-1.58%)
GILD   66.93 (-0.22%)
DIS   146.21 (-0.98%)
Log in

NYSE:GEN - Genesis Healthcare Stock Price, Forecast & News

$1.70
-0.02 (-1.16 %)
(As of 12/9/2019 04:00 PM ET)
Today's Range
$1.68
Now: $1.70
$1.79
50-Day Range
$1.28
MA: $1.53
$1.72
52-Week Range
$0.92
Now: $1.70
$1.79
Volume665,731 shs
Average Volume217,374 shs
Market Capitalization$280.17 million
P/E RatioN/A
Dividend YieldN/A
Beta1.04
Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. Read More…

Industry, Sector and Symbol

Industry Skilled nursing care facilities
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone610-444-6350

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.98 billion
Cash Flow$0.41 per share
Book Value($12.65) per share

Profitability

Net Income$-235,230,000.00

Miscellaneous

Employees61,300
Market Cap$280.17 million
Next Earnings Date3/16/2020 (Estimated)
OptionableOptionable

Receive GEN News and Ratings via Email

Sign-up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.


Genesis Healthcare (NYSE:GEN) Frequently Asked Questions

What is Genesis Healthcare's stock symbol?

Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

How were Genesis Healthcare's earnings last quarter?

Genesis Healthcare Inc (NYSE:GEN) released its quarterly earnings results on Thursday, November, 7th. The company reported $0.40 EPS for the quarter, beating the Zacks' consensus estimate of ($0.09) by $0.49. The firm earned $1.12 billion during the quarter, compared to the consensus estimate of $1.13 billion. View Genesis Healthcare's Earnings History.

When is Genesis Healthcare's next earnings date?

Genesis Healthcare is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Genesis Healthcare.

What is the consensus analysts' recommendation for Genesis Healthcare?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Genesis Healthcare.

Has Genesis Healthcare been receiving favorable news coverage?

News stories about GEN stock have been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Genesis Healthcare earned a news impact score of -1.7 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Genesis Healthcare.

Who are some of Genesis Healthcare's key competitors?

What other stocks do shareholders of Genesis Healthcare own?

Who are Genesis Healthcare's key executives?

Genesis Healthcare's management team includes the folowing people:
  • Mr. George V. Hager Jr., CEO & Director (Age 63)
  • Mr. Thomas DiVittorio, CFO, Exec. VP, Treasurer & Assistant Sec. (Age 51)
  • Mr. Paul David Bach, COO & Exec. VP (Age 60)
  • Dr. JoAnne Susan Reifsnyder Ph.D., MSN, MBA, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer (Age 60)
  • Mr. Richard L. Castor, Chief Information Officer & Sr. VP (Age 64)

Who are Genesis Healthcare's major shareholders?

Genesis Healthcare's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include V3 Capital Management L.P. (2.76%), Chevy Chase Trust Holdings Inc. (1.48%), State Street Corp (0.69%), Millennium Management LLC (0.55%), Virtu Financial LLC (0.03%) and Barclays PLC (0.03%). Company insiders that own Genesis Healthcare stock include David A Reis, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Institutional Ownership Trends for Genesis Healthcare.

Which institutional investors are selling Genesis Healthcare stock?

GEN stock was sold by a variety of institutional investors in the last quarter, including Barclays PLC. Company insiders that have sold Genesis Healthcare company stock in the last year include Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach and Thomas Divittorio. View Insider Buying and Selling for Genesis Healthcare.

Which institutional investors are buying Genesis Healthcare stock?

GEN stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, Chevy Chase Trust Holdings Inc., V3 Capital Management L.P., State Street Corp and Virtu Financial LLC. View Insider Buying and Selling for Genesis Healthcare.

How do I buy shares of Genesis Healthcare?

Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Genesis Healthcare's stock price today?

One share of GEN stock can currently be purchased for approximately $1.70.

How big of a company is Genesis Healthcare?

Genesis Healthcare has a market capitalization of $280.17 million and generates $4.98 billion in revenue each year. The company earns $-235,230,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. Genesis Healthcare employs 61,300 workers across the globe.View Additional Information About Genesis Healthcare.

What is Genesis Healthcare's official website?

The official website for Genesis Healthcare is http://www.genesishcc.com/.

How can I contact Genesis Healthcare?

Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected]


MarketBeat Community Rating for Genesis Healthcare (NYSE GEN)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  389 (Vote Outperform)
Underperform Votes:  360 (Vote Underperform)
Total Votes:  749
MarketBeat's community ratings are surveys of what our community members think about Genesis Healthcare and other stocks. Vote "Outperform" if you believe GEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/9/2019 by MarketBeat.com Staff

Featured Article: Stock Split

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel